Literature DB >> 24398879

HBsAg seroclearance with NUCs: rare but important.

Markus Cornberg1, Christoph Höner Zu Siederdissen1.   

Abstract

Keywords:  HEPATITIS B

Mesh：

Substances：

Year:  2014        PMID： 24398879     DOI： 10.1136/gutjnl-2013-306221

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

Review 1.  Management of HBV and HBV/HDV-Associated Liver Cirrhosis.

Authors:  Christoph Höner Zu Siederdissen; Markus Cornberg
Journal:  Visc Med       Date:  2016-04-12

2.  Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans.

Authors:  Chen Tian; Yuxin Chen; Yong Liu; Shixia Wang; Yang Li; Guiyang Wang; Juan Xia; Xiang-An Zhao; Rui Huang; Shan Lu; Chao Wu
Journal:  Emerg Microbes Infect       Date:  2018-02-16       Impact factor: 7.163

3.  T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model.

Authors:  Xiuxiu Sang; Ruilin Wang; Yanzhong Han; Cong'en Zhang; Honghui Shen; Zhirui Yang; Yin Xiong; Huimin Liu; Shijing Liu; Ruisheng Li; Ruichuang Yang; Jiabo Wang; Xuejun Wang; Zhaofang Bai; Xiaohe Xiao
Journal:  Acta Pharm Sin B       Date:  2017-05-02       Impact factor: 11.413

4.  Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg-Negative CHB.

Authors:  Maximilian Wübbolding; Juan Carlos Lopez Alfonso; Chun-Yen Lin; Sebastian Binder; Christine Falk; Jennifer Debarry; Paul Gineste; Anke R M Kraft; Rong-Nan Chien; Benjamin Maasoumy; Heiner Wedemeyer; Wen-Juei Jeng; Michael Meyer Hermann; Markus Cornberg; Christoph Höner Zu Siederdissen
Journal:  Hepatol Commun       Date:  2020-11-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.